Bergmark, B. A. Et Al. 2020. An Exploratory Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER Trial. JAMA CARDIOLOGY , vol.5, no.6 , 709-713.

Bergmark, B. A., O'Donoghue, M. L., Murphy, S. A., Kuder, J. F., Ezhov, M. V., Ceska, R., ... Gouni-Berthold, I.(2020). An Exploratory Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER Trial. JAMA CARDIOLOGY , vol.5, no.6, 709-713.

Bergmark, Brian Et Al. "An Exploratory Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER Trial," JAMA CARDIOLOGY , vol.5, no.6, 709-713, 2020

Bergmark, Brian A. Et Al. "An Exploratory Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER Trial." JAMA CARDIOLOGY , vol.5, no.6, pp.709-713, 2020

Bergmark, B. A. Et Al. (2020) . "An Exploratory Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER Trial." JAMA CARDIOLOGY , vol.5, no.6, pp.709-713.

@article{article, author={Brian A. Bergmark Et Al. }, title={An Exploratory Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER Trial}, journal={JAMA CARDIOLOGY}, year=2020, pages={709-713} }